Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 23 resultados

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE REGION SKANE participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

PREPARE: An EU-wide springboard for regional implementation of innovation procurement REGION SKANE participó en un HORIZON EUROPE: HORIZON-EIE-2022-CONNECT-01 This project is a preparatory action for creating innovation procurement policies and instruments that can be effective and sustainable at r...
2023-11-23 - 2024-11-30 | Financiado

Invest4Health: Mobilising novel finance models for health promotion and disease prevention REGION SKANE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08 In the medium to longer-term, the fiscal space that governments have to provide additional budgetary resources will shrink, including for he...
2023-01-01 - 2026-06-30 | Financiado

Procure4Health: Healthcare Innovation Procurement Network REGION SKANE participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 The objective is to create a network/community/ecosystem of procurers and relevant stakeholders in PPI. The idea is to empower all the actor...
2022-05-20 - 2025-05-31 | Financiado

Carematrix PCP: Pre commercial procurement for integrated CARE solutions addressing the Multimorbidity mATRIX in age... REGION SKANE participó en un H2020: H2020-SC1-BHC-2018-2020 Over 50m people suffer from multimorbidity (PMM) in Europe. Recent reviews find that PMM experience a range of system and professional-relat...
2021-02-03 - 2025-12-31 | Financiado

INNODIA HARVEST: Translational approaches to disease modifying therapy of type 1 diabetes HARVESTing the fruits of... REGION SKANE participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Building on the strong foundations of INNODIA, with its unique, Europe-wide clinical and basic research network for the study of type 1 diab...
2020-04-16 - 2024-04-30 | Financiado

HEDIMED: Human Exposomic Determinants of Immune Mediated Diseases REGION SKANE participó en un H2020: H2020-SC1-BHC-2018-2020 Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challen...
2019-12-06 - 2024-12-31 | Financiado

iLIVE: Living well dying well. A research programme to support living until the end REGION SKANE participó en un H2020: H2020-SC1-BHC-2018-2020 Every year around 4 million people die in the EU as a result of chronic disease and illness. Many will die in pain or distress, die alone, a...
2018-12-10 - 2023-12-31 | Financiado

PAPA-ARTIS: Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with Minimally Invasive... REGION SKANE participó en un H2020: H2020-SC1-2016-2017 Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue t...
2016-12-12 - 2024-09-30 | Financiado

TreatER: Clinical study in Parkinson s disease with two unique goals 1 Proof of concept of CDNF protein for... REGION SKANE participó en un H2020: H2020-SC1-2016-2017 The main focus of TreatER is conducting a randomized, placebo-controlled, first-in-human, proof-of-concept, safety and efficacy study of int...
2016-12-09 - 2020-12-31 | Financiado

SYNDEGEN: Synaptic dysfunction in Neurodegenerative Diseases REGION SKANE participó en un H2020: H2020-MSCA-ITN-2016 Neurodegenerative diseases (NDDs) of aging are a growing burden on societies. Although studies on the degeneration of neurons have been a ma...
2016-08-31 - 2021-06-30 | Financiado

INNODIA: Translational approaches to disease modifying therapy of type 1 diabetes an innovative approach tow... REGION SKANE participó en un H2020: H2020-JTI-IMI2-2014-01-two-stage Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findi...
2015-12-07 - 2023-10-31 | Financiado

BIOCYCLE: BIOlogical therapy CYCLEs towards tailored needs driven safer and cost effective management of Cro... REGION SKANE participó en un H2020: H2020-PHC-2014-2015 "The BIOCYCLE Project proposes to test and critically assess the benefits and risks of an innovative regimen for improving the treatment of...
2015-03-31 - 2022-12-31 | Financiado

EU-CERT-ICD: Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverte... REGION SKANE participó en un FP7: An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylact...
Financiado

PROFNAIT: Development of a prophylactic treatment for the prevention of fetal neonatal alloimmune thrombocytop... REGION SKANE participó en un FP7: Objective--The project aims to develop an anti HPA-1a immunoglobulin (IgG), Tromplate® that can prevent post delivery immunisation of the mo...
Financiado

NRT: Phase II clinical trial of PDGF BB for the neurological regeneration and recovery in Parkinson s dis... The goal of this project is to perform a European phase II clinical trial to demonstrate that PDGF-BB acts as a unique regenerative therapy...
Financiado

ECNIS2: ECNIS2 towards ECNIS Centre for Research and Education on Cancer Environment and Food REGION SKANE participó en un FP7: "The proposed project ECNIS2 aims at continuing the integrative and coordinative works initiated during ECNIS network with an ultimate goal...
Financiado

EUROHYP-1: European multicentre randomised phase III clinical trial of hypothermia plus best medical treatmen... REGION SKANE participó en un FP7: The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial w...
Financiado

READI FOR HEALTH: Regional Digital Agendas for Healthcare REGION SKANE participó en un FP7: READi for Health aims to strengthen the research potential of four leading eHealth regions (Murcia, Skane, Oulu and Midi-Pyrénées) by suppor...
Financiado

EEC: EURO EWING Consortium International Clinical Trials to Improve Survival from Ewing Sarcoma REGION SKANE participó en un FP7: Ewing Sarcomas (ES) are fatal, rare bone cancers particularly affecting young people. About 60% of patients achieve long term survival with...
Financiado

SKANE LAN